Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2024

May 2, 2024

284_dirs_2024-05-02_022544d6-2eb7-443f-b7d9-debf87798722.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2024-04-30

Reporting Person: Smart Dalton (SVP Fin. - Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-02 Common Stock M 381 $128.80 Acquired 3048.286 Direct
2024-05-02 Common Stock F 131 $128.80 Disposed 2917.286 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-04-30 Restricted Stock Unit $ A 1393 Acquired 2027-04-30 Common Stock (1393) Direct
2024-04-30 Stock Option (Right to Buy) $129.22 A 7031 Acquired 2034-04-29 Common Stock (7031) Direct
2024-05-02 Restricted Stock Unit $ M 381 Disposed 2026-05-02 Common Stock (381) Direct

Footnotes

F1: Includes .041 shares of Merck & Co., Inc. common stock not previously reported due to a clerical error.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

F4: The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.